1 / 25

Chronic Heart Failure: What, why and how to monitor in the home

Chronic Heart Failure: What, why and how to monitor in the home. Sean Collins, PT, ScD Chair & Associate Professor, Physical Therapy Associate Professor, Biomedical Engineering Director, Human Assessment Lab. Learning with Purpose. Learning with Purpose. What is the problem?.

kamil
Download Presentation

Chronic Heart Failure: What, why and how to monitor in the home

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic Heart Failure:What, why and how to monitor in the home • Sean Collins, PT, ScD • Chair & Associate Professor, Physical Therapy • Associate Professor, Biomedical Engineering • Director, Human Assessment Lab Learning with Purpose Learning with Purpose

  2. What is the problem? Hospital readmit rates following discharge with CHF • 25% readmissions after 1 month • 50% readmissions after 6 months • Unplanned readmissions account for nearly 15-20% of total Medicare expenditure on acute hospital care (“frequent flyers” - - - “S/he will be back in a week.....” • 1/2 to 2/3 appear to be associated with preventable factors (poor planning, non adherence to diet / meds, inadequate social support, delays in seeking treatment) Desai, A. S. (2012).Circulation, 125(6), 828–836. Learning with Purpose

  3. What, why and how to monitor • What to monitor : Stability (Broadly defined) • Why: Instability leads to admission (readmission) • How: The right information, at the right time, to make the right decisions…… • AND – teaching the patient to think & act using the same approach

  4. Examination – Evaluation Cycle Patient: State/Trait Examination: Collect information Intervention Evaluation: Integrate information into action

  5. What, why and how to monitor Desai, A. S. (2012).Circulation, 125(6), 828–836.

  6. Important Questions Is this patient stable? • What is stability? • What are the dimensions of stability? • Core concepts • Homeostasis • Allostasis • Why is stability impaired in CHF? • Why does this relate to hospitalization / re hospitalization? • How can we assess stability? Learning with Purpose

  7. Stability cycles Coordinated & Focused Muscular Activity Work Environment Bioenergetic Process O2 Glucose H2O Ventilation CV System Respiration

  8. Stability cycles Learning with Purpose

  9. Important Questions Underlying philosophical issues with questions of stability • Determining cause and effect • Inductive Inference • Deductive inference • Affirming the consequent / Abductive inference • Probability & Prediction Learning with Purpose

  10. Probability & Prediction

  11. Important Questions What needs to happen for this patient to stay stable? • What are necessary conditions for stability in any person? • Homeostasis / allostasis Learning with Purpose

  12. Important Questions What needs to happen for this patient to stay stable? • What is added to these necessary conditions for a person with CHF? • How do we supplement a person with CHF for homeostasis / allostasis? Learning with Purpose

  13. Important Questions What needs to happen for this patient to stay stable? • Does this particular patient meet these conditions? Learning with Purpose

  14. Important Questions What needs to happen for this patient to stay stable? • Are there reasons to believe they may have problems meeting these conditions in the future? Learning with Purpose

  15. What, Why, How? What is needed? Why? How? • What? • ‘….availability of an accurate and responsive measure of volume status is critical.’ • Why? • ‘Changes in filling pressures are often apparent several weeks before symptoms worsen.’ (Desai, 2012) • How? • Weight: < 50% of patients gain more than 2 lbs (0.9 kg) prior to decompensation; rapid weight gain is a specific but not a sensitive predictor Learning with Purpose

  16. What can be done? Why and how? • Dyspnea, Orthopnea • Pulmonary Rales • Peripheral edema • JVD • S3 Gallop • BP response to valsalva • Hypo responsive blood pressure • Heart rate variability Learning with Purpose

  17. What can be done? Dyspnea, Orthopnea, Peripheral Edema, Rales • Dyspnea • ~50% specificity and sensitivity • Edema • ~80% specificity, 36% sensitivity • Orthopnea • ~88% specificity, 50 sensitivity • Rales • ~70% specificity and sensitivity Learning with Purpose

  18. What can be done? JVD • Related to filling pressures • Need to assess from the beginning of care and correlate with other signs / symptoms • JVD specificity 94%, sensitivity 39% Learning with Purpose

  19. What can be done? S3 Gallop • S3 is suggestive of elevated PCWP • specificity 99%, sensitivity 20% Learning with Purpose

  20. What can be done? Hypo responsive blood pressure to activity • Expect ~ 10 (+/-2) mm Hg increase per MET increase in workload • Hypo responsive BP is an indicator of poor CO response • Drops in BP to workload is a stronger indicator of ineffective CO response • Need to assess in context – based on a history of knowing how this person responds Learning with Purpose

  21. What can be done? BP response to valsalva • Find Systolic BP (SBP) • Raise cuff pressure to 15 mmHg above SBP during normal breathing • Have patient perform VM (to about 30 mm Hg if using a manometer) for 10 seconds while auscultating the brachial artery • A: if hear Korotkoff sounds, then they disappear and reappear • B: if hear sounds, then disappear and do not reappear • C: If hear sounds and they do not disappear until after VM is released Learning with Purpose

  22. What can be done? BP response to valsalva • Zema et al (1980, 1984) have found specificity 80% and sensitivity 80% for non Sinusoidal responses for elevated LVEDP • Weilenmann et al (2002) found BP response to valsalva to be related to PCWP (R^2 = .75); and a specificity 95% and sensitivity 91% for identifying a PCWP > 15 mm Hg Learning with Purpose

  23. What can be done? Heart rate variability • Adamson et al (2004) showed that reductions in HRV (SDANN) and activity tended to precede readmission by up to 3 weeks with a specificity and sensitivity of 70% • Difficult to discern whether this could as easily be assessed with physical activity monitors as there is a strong relationship between HRV and activity Learning with Purpose

  24. What else can be done? On the horizon…… • Smaller non invasive sensors • Implantable sensors • Multimodal sensor / data integration • Human Assessment Lab at UMass Lowell • Acoustic cardiology • Physical activity • Heart rate variability • Pulse transit time Learning with Purpose

  25. Thank you! • Questions? • These slides are available at: • http://cardiopulmonarypt.wiki.uml.edu • Follow the link to the left to “Miscellaneous Presentations” Learning with Purpose

More Related